TEDDY - The Environmental Determinants of Diabetes in the Young
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The long-term goal of the TEDDY study is the identification of infectious agents, dietary factors, or other environmental agents, including psychosocial factors which trigger T1DM in genetically susceptible individuals or which protect against the disease. Identification of such factors will lead to a better understanding of disease pathogenesis and result in new strategies to prevent, delay or reverse T1DM.
| Condition |
|---|
|
Type 1 Diabetes Mellitus |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Consortium for Identification of Environmental Triggers of Type 1 Diabetes |
Serum, plasma, PBMCs, stool, saliva, nasal swabs, nail clippings, water
| Enrollment: | 8668 |
| Study Start Date: | September 2004 |
| Estimated Study Completion Date: | September 2025 |
Epidemiologic patterns suggest that viruses, nutrition, toxic agents or socioeconomic psychosocial factors may contribute to the etiology alone or in combination. Elucidation is confounded by the long interval between exposure and onset of clinical disease, as well as the interaction of multiple genes and/or insults, which appear to interact in a complex manner. Numerous studies have investigated environmental influences but have yielded conflicting results. This may be in part due to the failure to account for genetic susceptibility, begin observation at early ages or in utero, and/or monitor subjects long term and frequently.
Hypotheses:
Initiation of persistent beta-cell autoimmunity and progression from beta-cell autoimmunity to diabetes is increased with:
- Exposure to a trigger factor during pregnancy, such as infections, preeclampsia, blood incompatibility, or birth weight.
- Differences in the timing of the introduction and/or the type of dietary constituents that include exposure to cereals or gluten, exposure to cow's milk during infancy and/or childhood, and short duration of breast- feeding;
- Lower intake of serum 25 hydroxyvitamin D in early infancy, vitamin E, anti-oxidants (e.g., carotenoids, ascorbic acid, selenium, or omega-3 fatty acids);
- Higher frequency of specific (e.g., enterovirus, rotavirus, or bacterial) infections, or non-specific childhood infections including those that exhibit molecular mimicry;
- Increased exposure to routine childhood immunizations and their timing;
- Environmental factors that may be contained in drinking water (e.g., low concentrations of zinc or high concentrations of nitrates, or lower pH levels);
- Exposure to household pets, and various allergies;
- Excessive weight gain;
- Increased psychological stress.
- The risk of persistent beta-cell autoimmunity is lower in children from the general population than in offspring or siblings of T1DM patients when stratifying for the HLA DR-DQ genotype and exposure to environmental triggers.
- The interaction of HLA DR-DQ genotype with exposure to dietary or infectious factors leads to increased incidence of beta-cell autoimmunity and T1DM.
- We expect that in some families study participation will be associated with affective (anxiety, depression) and behavioral responses (e.g. actions to prevent possible T1DM).
Eligibility| Ages Eligible for Study: | up to 4 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Childen up to 4 months of age with specified HLA are enrolled and followed longitudnally until 15 years of age
Inclusion Criteria:
- Newborns with high risk HLA in the general population or having a first- degree relative affected with T1DM
- Newborns are less than 4 months of age
Exclusion Criteria:
- Have an illness or birth defect that precludes long-term follow-up or involves use of treatment that may alter the natural history of diabetes (e.g. steroids or insulin)
- Refuses to have blood and stool samples stored at the NIDDK Repository
Contacts and Locations| United States, Colorado | |
| University of Colorado Health Sciences Center | |
| Denver, Colorado, United States, 80262 | |
| United States, Florida | |
| Medical College of Georgia | |
| Gainesville, Florida, United States, 32608 | |
| United States, Georgia | |
| Medical College of Georgia | |
| Atlanta, Georgia, United States, 30342 | |
| Medical College of Georgia | |
| Augusta, Georgia, United States, 30912 | |
| United States, Pennsylvania | |
| Children's Hospital of Pittsburgh of UPMC (this site is only screening babies whose mother, father or full sibiling have type 1 diabetes) | |
| Pittsburgh, Pennsylvania, United States, 15213 | |
| United States, Washington | |
| Pacific Northwest Diabetes Research Institute | |
| Seattle, Washington, United States, 98122 | |
| Finland | |
| Turku University Central Hospital | |
| Turku, Finland, 20520 | |
| Germany | |
| Diabetes Research Institute | |
| Munich, Germany, 80804 | |
| Sweden | |
| University of Lund | |
| Malmo, Sweden, 20502 | |
| Principal Investigator: | Jeffrey P. Krischer, PhD | University of South Florida |
| Principal Investigator: | Marian J. Rewers, MD, PhD | University of Colorado Health Science Center |
| Principal Investigator: | William A. Hagopian, MD, PhD | Pacific Northwest Research Institute |
| Principal Investigator: | Ake Lernmark, MD, PhD | University of Washington & University of Lund |
| Principal Investigator: | Olli G. Simell, MD, PhD | University of Turku |
| Principal Investigator: | Jin-Xiong She, PhD | Georgia Regents University |
| Principal Investigator: | Anette G. Ziegler, MD | University of Miami |
| Principal Investigator: | Beena Akolkar, PhD | National Institutes of Diabetes and Digestive Kidney Diseases |
More Information
Additional Information:
No publications provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr. Jeffrey Krischer, University of South Florida |
| ClinicalTrials.gov Identifier: | NCT00279318 History of Changes |
| Other Study ID Numbers: | DK63790, 5U01DK063790-04 |
| Study First Received: | January 17, 2006 |
| Last Updated: | February 1, 2011 |
| Health Authority: | United States: Federal Government United States: Institutional Review Board |
Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
|
Environment Exposures Diet Toxins Psychosocial |
Infectious Agents Bacterial Viral Immunizations Autoantibody |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Autoimmune Diseases Immune System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013